79324346

Information

  • Trademark
  • 79324346
  • Serial Number
    79324346
  • Registration Number
    6909089
  • Filing Date
    April 29, 2021
    3 years ago
  • Registration Date
    November 29, 2022
    2 years ago
  • Transaction Date
    May 08, 2024
    8 months ago
  • Status Date
    November 29, 2022
    2 years ago
  • Published for Opposition Date
    September 13, 2022
    2 years ago
  • Location Date
    July 10, 2023
    a year ago
  • Status Code
    700
  • Current Location
    TMO LAW OFFICE 111
    Employee Name
    SEVERSON, JUSTIN
  • Attorney Docket Number
    2078154-0005
    Law Office Assigned Location Code
    M20
  • Owners
Mark Drawing Code
2
Case File Statements
  • DM0000: The mark consists of a stylised representation of an organoid in blue outline. The colour white represents background and/or transparent areas and is not claimed as a feature of the mark.
  • B00001: In the statement, line 8-9, cell culture reagents for scientific and research use, should be deleted.
  • GS0051: Cells for medical and veterinary research, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems, liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; stem cells for medical and veterinary, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems, liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; epithelial cells for medical and veterinary, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems, liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; organoids, namely, self-organized three-dimensional tissue cultures derived from stem cells and cell cultures for medical and veterinary research, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems, liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; cell cultures for medical and veterinary research, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems, liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; diagnostic and analytical preparations for medical purposes; chemicals for use in scientific medical research for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems, liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; culture media for medical and veterinary use, namely, for use in diagnosis and treatment of diseases of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems, liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; biological tissue cultures for medical and veterinary purposes; assays and assay preparations for medical and veterinary diagnostic testing of cells, cultures and organoids for therapeutic purposes; pharmaceutical and veterinary preparations and substances for the treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems, liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; cells, epithelial cells, organoids and cell cultures for personalised medicine, namely, for diagnosis and treatment of diseases of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems, liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx
  • CC0000: The color(s) blue is/are claimed as a feature of the mark.
  • GS0011: Cells, stem cells, and epithelial cells, all for scientific research purposes; organoids, namely, self-organized three-dimensional tissue cultures derived from stem cells and cell cultures, for scientific research use; cell culture reagents for scientific and research use; cell culture media for scientific and research use; diagnostic and analytical preparations for use in science; chemicals used in science and industry; assays and assay preparations for scientific purposes; cell culture media for scientific research purposes
  • GS0441: Medical services and surgery; medical and surgical diagnostic services; medical services in the nature of cell transplantation services
  • GS0421: Scientific research services; genetic testing for scientific research purposes; medical and pharmacological research services; pharmaceutical drug and vaccine development services; development of pharmaceutical preparations and medicines; medical compound, drug and vaccine discovery, development, characterization and validation services in the nature of product quality and efficacy testing for medical compounds, drugs and vaccines; candidate drug and vaccine testing services, namely, testing of pharmaceuticals; compound, drug and vaccine testing services; companion diagnostics, namely, the scientific testing and evaluation of drugs and vaccines for individuals or groups of patients to determine the safety and effectiveness of the drug or vaccine for those patients; food safety testing services; testing of compounds and substances to determine toxicity to cells and organoids, namely, self-organized three-dimensional tissue cultures derived from stem cells and cell cultures; scientific research and diagnostic services in the field of personalised medicine
Case File Event Statements
  • 12/18/2021 - 3 years ago
    5 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 1/14/2022 - 2 years ago
    8 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 10/28/2021 - 3 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 11/4/2021 - 3 years ago
    2 - LIMITATION FROM ORIGINAL APPLICATION ENTERED Type: LIMI
  • 11/5/2021 - 3 years ago
    3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 11/9/2021 - 3 years ago
    4 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 12/29/2021 - 3 years ago
    6 - ASSIGNED TO EXAMINER Type: DOCK
  • 1/13/2022 - 2 years ago
    7 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 2/3/2022 - 2 years ago
    9 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 7/14/2022 - 2 years ago
    12 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 7/14/2022 - 2 years ago
    13 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 7/14/2022 - 2 years ago
    14 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 7/14/2022 - 2 years ago
    15 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 7/14/2022 - 2 years ago
    16 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 8/1/2022 - 2 years ago
    19 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 2/3/2022 - 2 years ago
    10 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 2/20/2022 - 2 years ago
    11 - REFUSAL PROCESSED BY IB Type: RFNT
  • 8/1/2022 - 2 years ago
    17 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 8/1/2022 - 2 years ago
    18 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 8/9/2022 - 2 years ago
    20 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 9/7/2022 - 2 years ago
    22 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 8/24/2022 - 2 years ago
    21 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 9/7/2022 - 2 years ago
    23 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 9/13/2022 - 2 years ago
    24 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 9/13/2022 - 2 years ago
    25 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 9/27/2022 - 2 years ago
    26 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 11/29/2022 - 2 years ago
    27 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 11/29/2022 - 2 years ago
    28 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 12/19/2022 - 2 years ago
    29 - TEAS SECTION 7 REQUEST RECEIVED Type: ES7R
  • 7/5/2023 - a year ago
    34 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 2/28/2023 - a year ago
    30 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 3/21/2023 - a year ago
    31 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 3/21/2023 - a year ago
    32 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 4/12/2023 - a year ago
    33 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 7/10/2023 - a year ago
    35 - CORRECTION UNDER SECTION 7 - PROCESSED Type: COC.
  • 7/10/2023 - a year ago
    36 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 8/15/2023 - a year ago
    37 - NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED Type: NURC
  • 3/19/2024 - 9 months ago
    39 - INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE Type: INNA
  • 4/5/2024 - 9 months ago
    40 - CHANGE OF OWNER RECEIVED FROM IB Type: CHLD
  • 5/7/2024 - 8 months ago
    41 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH
  • 3/10/2024 - 10 months ago
    38 - PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INPR